CN Stock MarketDetailed Quotes

300199 Hybio Pharmaceutical

Watchlist
  • 12.89
  • -0.08-0.62%
Market Closed Dec 31 15:00 CST
11.38BMarket Cap-30.91P/E (TTM)

Hybio Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hybio Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2019/FY614.191M / 2.119B--
DatePeriodRevenue/EstimateEarnings Call
--2019/FY614.191M / 2.119B--

Hybio Pharmaceutical Earnings Reports

  • Hanyu Pharmaceutical: Report for the third quarter of 2024

    Oct 29, 2024 12:00 ET

  • Hybio Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 23, 2024 12:00 ET

  • Hybio Pharmaceutical: Half-year report for the year 2024.

    Aug 23, 2024 12:00 ET

  • Hybio Pharmaceutical: 2023 Annual Report Summary

    Apr 26, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme The Concept of Three Children
    The Concept of Three Children
    Intraday-0.99%
    Innovative Drugs
    Innovative Drugs
    Intraday-1.65%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-1.72%